A Study of Markers of Glucocorticoid Effects in Patients With Addisons Disease (DOSCORT)

Key facts

Sponsor

Göteborg University

Principal Investigator

Gudmundur Johannsson, Prof., MD

Vastra Gotaland Region, Sahlgrenska University Hospital, dept. of Endocrinology

Intervention

Betamethasone(drug)

Enrollment

30 enrolled

Eligibility

20-65 years · All sexes

Timeline

2021 – 2022

Study locations (1)

• Centrum for Endocrinology and Metabolism, Sahlgenska University Hospital, Gothenburg, Sweden

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Addison disease

Additional recruiting or active studies for the same condition.

• RECRUITINGNCT06955286
  Study on the Incidence of Adrenal Insufficiency After Surgery in Primary Aldosteronism Patients Concurrent With or Without Autonomous Cortisol Secretion
  Qifu Li

See all trials for Addison disease →